diaziquone has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, LH; Bonnet, JD; Crowley, J; Hanson, KH; Larrimer, NR; Stuckey, WJ; White, LA | 1 |
| Anderson, K; McIntyre, OR; Vinciguerra, V | 1 |
1 trial(s) available for diaziquone and Multiple Myeloma
| Article | Year |
|---|---|
Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Thrombocytopenia | 1985 |
1 other study(ies) available for diaziquone and Multiple Myeloma
| Article | Year |
|---|---|
Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Male; Middle Aged; Multiple Myeloma | 1987 |